LMLiwei Ma

Liwei Ma

*This is an algorithmically generated author record based on publicly available information.

Liwei Ma has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Chao Hou

    Department of Systems Biology, Columbia University Irving Medical Center, New York, NY 10032

    1 shared publication
  • Feng Zhu

    Research Center on Aging, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function

    1 shared publication
  • Guodong Li

    Research Center on Aging, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function

    1 shared publication
  • Guoguo Tang

    Department of Ophthalmology, Peking University Third Hospital, Beijing 100191, China

    1 shared publication
  • Nan Xie

    Research Center on Aging, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function

    1 shared publication
  • Tanjun Tong

    Peking University Health Science Center

    1 shared publication

Latest Publications

  • Open Access

    PhaSeDis: A Manually Curated Database of Phase Separation–Disease Associations and Corresponding Small Molecules

    by Taoyu Chen, Guoguo Tang, Tianhao Li, Zhining Yanghong, Chao Hou, Zezhou Du, Liwei Ma, Tingting Li

    Biomacromolecules form membraneless organelles through liquid–liquid phase separation in order to regulate the efficiency of particular biochemical reactions. Dysregulation of phase separation might result in pathological condensation or sequestration of biomolecules, leading to diseases. Thus, phase separation and phase separating factors may serve as drug targets for disease treatment. Nevertheless, such associations have not yet been integrated into phase separation related databases. Therefore, based on MloDisDB, a database for membraneless organelle factor–disease association previously developed by our lab, we constructed PhaSeDis, the phase separation–disease association database. We increased the number of phase separation entries from 52 to 185, and supplemented the evidence provided by the original article verifying the phase separation nature of the factors. Moreover, we included the information of interacting small molecules with low or high-throughput evidence that might serve as potential drugs for phase separation entries. PhaSeDis strives to offer comprehensive descriptions of each entry, elucidating how phase separating factors induce pathological conditions via phase separation and the mechanisms by which small molecules intervene. We believe that PhaSeDis would be very important in the application of phase separation regulation in treating related diseases. PhaSeDis is available at http://mlodis.phasep.pro .

  • The Cellular Senescence-Inhibited Gene Is Essential for PPM1A Myristoylation To Modulate Transforming Growth Factor β Signaling

    by Feng Zhu, Nan Xie, Zhe Jiang, Guodong Li, Liwei Ma, Tanjun Tong

    The cellular senescence-inhibited gene (CSIG) is implicated in important biological processes including cellular senescence and apoptosis. Our work showed that CSIG is involved in serine/threonine protein phosphatase PPM1A myristoylation. Previous research has shown, the myristoylation is necessary for PPM1A dephosphorylating Smad2/3. However, the control and the biological significance of the myristoylation remain poorly understood. In this study, we found that CSIG knockdown disturbs PPM1A myristoylation and reduces PPM1A dephosphorylating its substrate Smad2. By regulating PPM1A myristoylation, CSIG involves in modulating TGFβ signaling. The further mechanism study indicated that CSIG facilitates the interaction between N-myristoyltransferase 1 (NMT1) and PPM1A. Totally, we found that CSIG is a regulator in PPM1A myristoylation and TGFβ signaling. Through promoting the myristoylation of PPM1A, CSIG enhanced the phosphatase activity of PPM1A and further inhibited the TGFβ signaling. This work not only extends the biological significance of CSIG but also provides new ideas and reference for the regulatory mechanism study of myristoylation.